Last reviewed · How we verify
MTBVAC live vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
MTBVAC live vaccine (MTBVAC live vaccine) — Biofabri, S.L.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| MTBVAC live vaccine TARGET | MTBVAC live vaccine | Biofabri, S.L | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- MTBVAC live vaccine CI watch — RSS
- MTBVAC live vaccine CI watch — Atom
- MTBVAC live vaccine CI watch — JSON
- MTBVAC live vaccine alone — RSS
Cite this brief
Drug Landscape (2026). MTBVAC live vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/mtbvac-live-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab